I would like to use the Tillotts name, logo, trademarks or other materials owned by Tillotts.
If you are interested in using the Tillotts name or logo, names and logos of our products or any other material, we require that you obtain prior written permission from us. As a narrow exception, certain photographs have been pre-approved for external use by third parties, provided that credit is incorporated. See Visuals for more information.
Where can I get information on employment with Tillotts?
To see our job availabilities, please visit the Careers Section of this Web site. Jobs, which are posted online on our website, are open and we are looking for applications. Here you can also learn more about the benefits, we offer.
We continue to proactively seek new partnerships for products for the digestive system and we invite our potential partners to explore the opportunities we can offer.
Our key areas of interest are:
Pharmaceutical products (in clinical development stage, registration or ready to market) for diseases of the digestive system.
Early-stage drug delivery concepts and technical platforms in the field of gastroenterology.
We consider a variety of collaboration forms, such as co-promotion, co-marketing, distribution/promotion, licence agreements or M&A.
Do Tillotts disclose financial payments made to healthcare professionals and organisations?
Yes, our disclosures regarding payments made to European healthcare professionals, healthcare organisations and patient organisations are consistent with the standards set forth in the Disclosure Code of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and national codes and laws, and follow the call for greater transparency in respect of these vital relationships. Disclosures will help to strengthen the basis for collaboration in the future. Click here to learn more about our disclosures in detail.
Where can I get Tillotts stockholder and financial information?
As part of the Japanese Zeria Group, we do not disclose financial information separately for Tillotts Pharma. Zeria Pharmaceutical Ltd. (“Zeria”) is listed on the First Section of Tokyo Stock Exchange (Stock code: 4559). Information regarding Zeria stockholder and financial can be found here.
How do I get a copy of your Annual Report?
As part of the Japanese Zeria Group, we do not disclose financial information separately for Tillotts Pharma AG. Information on Zeria financial data can be found here.
Website Feedback
Please send email to communication@tillotts.com to report a Web site problem or make suggestions to improve the Tillotts Web site.
Product Information
I have a question about one of your pharmaceutical products.
Visit the Products Section on this Web site to find information about our products. If you are a Healthcare Professional or Consumer seeking medical information about our prescription products, please contact our Medical team.
What is a product complaint?
A product complaint is information about a problem with a Tillotts product.
Why should you report product complaints to Tillotts?
By reporting a product complaint, you provide us with important feedback about our products.
How do I report a product complaint?
Please use the form here.
How does Tillotts handle privacy in connection to product complaints?
All personal information related to the reporting of a product complaint is processed in accordance with applicable data protection legislation.
Media Relations
Where can I find news and press releases about Tillotts?
To view a listing of Tillotts’ press releases and general news, please visit our News Section.
I would like to use one or more of your photos for my story. What should I do?
We have some photos which have been pre-approved for external use by third parties, see here. Please remember to credit the photo as indicated. If you wish to use another picture, please e-mail Corporate Communications and let us know the purpose for which the photo or video will be used, any specifications and your deadline.
How do I request an interview with a Tillotts executive?
Please e-mail Tillotts Corporate Communications and let us know which Tillotts executive you would like to interview, the nature of the interview, your contact information and your deadline.
Please provide one or more of the following pieces of information regarding yourself, as the individual reporting the information regarding the side effectUveďte prosím jeden nebo více ze svých osobních údajů jako osoby, která podává hlášení vedlejšího účinkuDu bedes angive en eller flere af følgende oplysninger om dig selv som den, der indberetter oplysningerne om bivirkningenVeuillez fournir un ou plusieurs des renseignements suivants pour vous identifier en tant que personne déclarant des informations concernant un effet indésirable anna vähintään yksi seuraavista tiedoista koskien itseäsi haittavaikutuksen ilmoittajanaMachen Sie bitte eine oder mehrere der folgenden Angaben zu Ihrer Person als Berichterstatter der Informationen bezüglich der NebenwirkungVinsamlegast veittu upplýsingar um eitt eða fleiri af eftirfarandi atriðum um þann sem tilkynnir um aukaverkunina (þig)Angi en eller flere av de følgende opplysningene om deg selv som individuell rapportering av informasjonen om bivirkningenPor favor, proporcione uno o más de los siguientes datos sobre usted, como persona que notifica la información relativa a la reacción adversaAnge något eller flera av följande fakta om dig som den person som rapporterar information om biverkningenFornire una o più delle seguenti informazioni sul Suo conto, in quanto soggetto che segnala le informazioni relative all'effetto indesideratoPlease provide one or more of the following pieces of information regarding the patient who experienced the side effect, in order to help us distinguish individual reportsUveďte prosím jeden nebo více osobních údajů pacienta, u kterého se vyskytl vedlejší účinek, abychom mohli rozlišit jednotlivá hlášeníDu bedes angive en eller flere af følgende oplysninger om den patient, der har oplevet bivirkningen, for at hjælpe os med at skelne imellem forskellige indberetningerVeuillez fournir un ou plusieurs des renseignements suivants pour vous identifier en tant que personne déclarant des informations concernant un effet indésirable anna vähintään yksi seuraavista tiedoista koskien haittavaikutuksen kokenutta potilasta, näin helpota yksittäisten raporttien erottamistaMachen Sie bitte eine oder mehrere der folgenden Angaben zum Patienten, bei dem die Nebenwirkung aufgetreten ist, um die einzelnen Meldungen voneinander abzugrenzenVinsamlegast veittu upplýsingar um eitt eða fleiri af eftirfarandi atriðum um sjúklinginn sem fann fyrir aukaverkun til að hjálpa okkur við að aðgreina einstakar tilkynningarAngi en eller flere av de følgende opplysningene om pasienten som opplevde bivirkningen for å hjelpe oss i å skille de enkelte rapportenePor favor, proporcione uno o más de los siguientes datos sobre el paciente que ha experimentado la reacción adversa para ayudarnos a distinguir los informes individualesAnge något eller flera av följande fakta om den patient som upplevde biverkningen, som en hjälp för oss att särskilja individuella rapporterAl fine di aiutarci a distinguere le singole segnalazioni la preghiamo di fornire una o più delle seguenti informazioni sul paziente che ha manifestato l'effetto indesideratoInitials means the first letters of both your first name(s) and your last name(s)Iniciály znamenají první písmena Vašeho křestního jména (jmen) a příjmeníInitialer betyder det første bogstav i fornavn(e) og efternavn(e)Première lettre de votre prénom et de votre nom de familleEtu- ja sukunimen ensimmäinen kirjainInitialen bedeutet die ersten Buchstaben von Vorname(n) und Nachname(n)Vinsamlegast veittu upplýsingar um eitt eða fleiri af eftirfarandi atriðum um sjúklinginn sem fann fyrir aukaverkun til að hjálpa okkur við að aðgreina einstakar tilkynningarinitialer betyr de første bokstavene av både fornavn(ene) og etternavn(ene)Iniciales hace referencia a las primeras letras de su nombre de pila y de su(s) apellido(s)Initialer avser de första bokstäverna i såväl dina för- som efternamncioè la prima lettera del Suo nome/dei Suoi nomi e la prima lettera del Suo cognome/dei Suoi cognomi
We use cookies on this website. By continuing to use our services, you are giving us your consent to use cookies.